SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Lal Pathlabs reports 56% fall in Q1 consolidated net profit

29 Jul 2022 Evaluate

Dr. Lal Pathlabs has reported results for first quarter ended June 30, 2022.

The company has reported a fall of 35.44% in its net profit at Rs 79.60 crore for the quarter under review as compared to Rs 123.30 crore for the same quarter in the previous year. Total income of the company decreased by 20.80% at Rs 458.10 crore for Q1FY23 as compared Rs 578.40 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 56.47% in its net profit at Rs 58.20 crore for the quarter under review as compared to Rs 133.70 crore for the same quarter in the previous year. Total income of the company decreased by 17.67% at Rs 511 crore for Q1FY23 as compared Rs 620.70 crore for the corresponding quarter previous year.

Dr. Lal Pathlabs Share Price

1651.70 85.05 (5.43%)
08-May-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×